Oligoclonal expansion of atypical Vδ2- γδ T cells in Good's Syndrome

dc.contributor.authorBandala Sánchez, Esther
dc.contributor.authorScolamiero, Laura
dc.contributor.authorChatelier, Josh
dc.contributor.authorRamsay, Kerry A.
dc.contributor.authorMorey, Alison
dc.contributor.authorTsang, Sylvia
dc.contributor.authorForde, Maureen
dc.contributor.authorBosco, Julian J.
dc.contributor.authorPumar, Marsus
dc.contributor.authorGuevara Hoyer, Kissy
dc.contributor.authoret al.
dc.date.accessioned2026-08-04T13:01:45Z
dc.date.available2026-08-04T13:01:45Z
dc.date.issued2026
dc.description.abstractGood’ssyndromeisarareadult-onsetimmunodeficiency characterized by thymoma, hypogammaglobulinemia, B-cell lymphopenia, and T-cell dysfunction. Despite well-characterized defects in conventional immune subsets, the impact of this disorder on unconventional Tcells, including γδ Tcells, remains largely unexplored. In this study, we analyse γδ T cells in 10 patients with Good’s syndrome using immunophenotyping, functional assays, and T-cell receptor (TCR)δ repertoire profiling of peripheral blood and thymoma tissue. Our analyses reveal a pronounced expansion of the Vδ2⁻ γδ T-cell compartment, composed primarily of Vδ1⁺,Vδ3⁺ and the exceptionally rare Vδ8⁺ subsets. The Vδ2⁻ cells are characterized by an activated and effector phenotype and a private and oligoclonal TCRδ repertoire. The thymoma tissue contains distinct clonotypes compared to circulation, suggesting clonal focusing in response to the tumor. Together, our findings show that γδ T-cell perturbations are integral characteristics of Good’s syndrome and broaden our understanding of immune dysregulation in this acquired immunodeficiency.en
dc.description.filiationUEM
dc.description.impact18.1 Q1 JCR 2025
dc.description.impact4.904 Q1 SJR 2025
dc.description.impactNo data IDR 2024
dc.description.sponsorshipEsta investigación cuenta con el apoyo del NationalHealth and Medical Research Council (NHMRC) con la subvención de investigador 2007884 (L.J.H.).es
dc.identifier.citationBandala-Sanchez, E., Scolamiero, L., Chatelier, J., Ramsay, K. A., Morey, A., Tsang, S., Forde, M., Bosco, J. J., Pumar, M., Sanchez-Ramon, S., Guevara-Hoyer, K., Fuentes-Antrás, J., Godsell, J., Spriggs, K., Von Borstel, A., Chan, S., & Howson, L. J. (2026). Oligoclonal expansion of atypical Vδ2− γδ T cells in Good’s Syndrome. Nature Communications, 17(1), 7439. https://doi.org/10.1038/s41467-026-74273-9
dc.identifier.doi10.1038/s41467-026-74273-9
dc.identifier.issn2041-1723
dc.identifier.urihttps://hdl.handle.net/11268/17357
dc.language.isoeng
dc.peerreviewedSi
dc.relation.publisherversionhttps://doi.org/10.1038/s41467-026-74273-9
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.otherBiociencias
dc.subject.otherSíndromes de Inmunodeficiencia
dc.subject.otherTimoma
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoCiencias médicas
dc.subject.unescoInmunología
dc.subject.unescoCáncer
dc.titleOligoclonal expansion of atypical Vδ2- γδ T cells in Good's Syndromeen
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Oligoclonal_expansion_atypical
Size:
4.49 MB
Format:
Adobe Portable Document Format